William Plovanic
Stock Analyst at Canaccord Genuity
Total Price Targets
29
Stocks Covered
15
Sectors
Healthcare
Most Recent
Feb 18, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by William Plovanic
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PODD | Insulet Corporation | $435.00 | $175.12 | +148.4% | 1 | Feb 18, 2026 |
| ATRC | AtriCure, Inc. | $53.00 | $29.16 | +81.8% | 2 | Feb 18, 2026 |
| BSX | Boston Scientific Corporation | $109.00 | $56.91 | +91.5% | 6 | Feb 17, 2026 |
| TNDM | Tandem Diabetes Care, Inc. | $35.00 | $19.34 | +81.0% | 3 | Dec 17, 2025 |
| AORT | Artivion, Inc. | $51.00 | $36.24 | +40.7% | 1 | Dec 17, 2025 |
| EW | Edwards Lifesciences Corporation | $87.00 | $84.24 | +3.3% | 6 | Dec 17, 2025 |
| SIBN | SI-BONE, Inc. | $27.00 | $13.21 | +104.5% | 1 | Dec 17, 2025 |
| PEN | Penumbra, Inc. | $355.00 | $325.86 | +8.9% | 1 | Nov 6, 2025 |
| DXCM | DexCom, Inc. | $99.00 | $61.51 | +61.0% | 2 | Oct 31, 2025 |
| CBLL | CeriBell, Inc. | $30.00 | $20.61 | +45.6% | 1 | Nov 5, 2024 |
| ANGO | AngioDynamics, Inc. | $12.00 | $11.22 | +7.0% | 1 | Oct 4, 2024 |
| IRTC | iRhythm Technologies, Inc. | $137.00 | $119.47 | +14.7% | 1 | Sep 25, 2024 |
| TMDX | TransMedics Group, Inc. | $169.00 | $100.16 | +68.7% | 1 | Aug 1, 2024 |
| LUNG | Pulmonx Corporation | $16.00 | $1.35 | +1080.8% | 1 | Aug 1, 2024 |
| BVS | Bioventus Inc. | $8.00 | $10.14 | -21.1% | 1 | May 7, 2024 |
Recent Activity
- Feb 18, 2026— Set$435.00price target onPODD(Insulet Corporation)
- Feb 18, 2026— Set$53.00price target onATRC(AtriCure, Inc.)
- Feb 17, 2026— Set$109.00price target onBSX(Boston Scientific Corporation)
- Feb 5, 2026— Set$112.00price target onBSX(Boston Scientific Corporation)
- Dec 17, 2025— Set$87.00price target onEW(Edwards Lifesciences Corporation)
- Dec 17, 2025— Set$51.00price target onAORT(Artivion, Inc.)
- Dec 17, 2025— Set$35.00price target onTNDM(Tandem Diabetes Care, Inc.)
- Dec 17, 2025— Set$131.00price target onBSX(Boston Scientific Corporation)
- Dec 17, 2025— Set$27.00price target onSIBN(SI-BONE, Inc.)
- Dec 5, 2025— Set$89.00price target onEW(Edwards Lifesciences Corporation)
- Nov 6, 2025— Set$355.00price target onPEN(Penumbra, Inc.)
- Nov 3, 2025— Set$84.00price target onEW(Edwards Lifesciences Corporation)
- Oct 31, 2025— Set$99.00price target onDXCM(DexCom, Inc.)
- Oct 30, 2025— Set$64.00price target onATRC(AtriCure, Inc.)
- Aug 7, 2025— Set$24.00price target onTNDM(Tandem Diabetes Care, Inc.)
- Apr 25, 2025— Set$75.00price target onEW(Edwards Lifesciences Corporation)
- Dec 5, 2024— Set$68.00price target onEW(Edwards Lifesciences Corporation)
- Nov 5, 2024— Set$30.00price target onCBLL(CeriBell, Inc.)
- Oct 21, 2024— Set$98.00price target onBSX(Boston Scientific Corporation)
- Oct 7, 2024— Set$66.00price target onEW(Edwards Lifesciences Corporation)
Frequently Asked Questions
Who is William Plovanic?
William Plovanic is a stock analyst at Canaccord Genuity covering 15 stocks primarily in Healthcare. They have issued 29 price targets since Oct 28, 2021.
What stocks does William Plovanic cover?
William Plovanic currently covers 15 stocks, including BSX, EW, TNDM, ATRC, DXCM.
What is William Plovanic's latest price target?
William Plovanic's most recent price target was $435.00 on PODD (Insulet Corporation), set on Feb 18, 2026.
What is William Plovanic's highest price target?
William Plovanic's highest issued price target is $435.00 on PODD, set on Feb 18, 2026.
More Analysts at Canaccord Genuity
Coverage based on publicly published price targets. Not investment advice.